WAVELIGHT ALLEGRETTO WAVE EXCIMER LASER SYSTEM

Excimer Laser System

FDA Premarket Approval P030008

This medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original pma or panel track supplement and may not represent the most recent labeling.

Pre-market Approval Supplement Details

Approval for the wavelight allegretto wave excimer laser system. The devices uses optical zones of 6. 0 and 6. 5 mm with an ablation/treatment zone up to 9. 0 mm, and is indicated for laser assisted in situ keratomileusis (lasik): 1) for the reduction or elimination of hyperopic refractive errors up to +6. 0 diopters (d) of sphere with and without astigmatic refractive errors up to 5. 0 d at the spectacle plane, with a maximum manifest refraction spherical equivalent (mrse) of +6. 0 d; 2) in patients who are 18 years of age or older; and 3) in patients with documentation of a stable manifest refraction defined as

DeviceWAVELIGHT ALLEGRETTO WAVE EXCIMER LASER SYSTEM
Classification NameExcimer Laser System
Generic NameExcimer Laser System
ApplicantAlcon Laboratories, Inc.
Date Received2003-03-19
Decision Date2003-10-10
Notice Date2003-10-28
PMAP030008
SupplementS
Product CodeLZS
Docket Number03M-0492
Advisory CommitteeOphthalmic
Expedited ReviewNo
Combination Product No
Applicant Address Alcon Laboratories, Inc. 6201 South Freeway fort Worth, TX 76134-2099
Summary:Summary of Safety and Effectiveness
Labeling: Labeling Labeling Part 2
Approval Order: Approval Order

Supplemental Filings

Supplement NumberDateSupplement Type
P030008Original Filing
S035 2021-09-02 Real-time Process
S034 2021-04-12 Real-time Process
S033 2021-01-19 Special (immediate Track)
S032 2020-12-04 30-day Notice
S031 2020-02-25 Normal 180 Day Track
S030 2019-09-16 Real-time Process
S029 2019-07-05 Real-time Process
S028 2019-02-21 Special (immediate Track)
S027 2018-09-26 30-day Notice
S026 2018-05-11 Real-time Process
S025 2018-02-27 Normal 180 Day Track
S024 2018-01-05 Real-time Process
S023 2017-09-28 Real-time Process
S022 2017-03-24 30-day Notice
S021
S020 2015-04-09 30-day Notice
S019 2015-02-27 Real-time Process
S018 2015-02-11 Real-time Process
S017 2015-02-02 Normal 180 Day Track
S016 2014-10-23 Real-time Process
S015 2014-08-14 Normal 180 Day Track
S014 2014-01-29 30-day Notice
S013 2014-01-22 Real-time Process
S012 2013-07-22 Real-time Process
S011 2013-04-17 Special (immediate Track)
S010 2013-01-18 Real-time Process
S009 2012-11-05 Normal 180 Day Track
S008 2012-07-30 Real-time Process
S007 2012-03-12 30-day Notice
S006 2011-04-04 Normal 180 Day Track
S005 2006-12-19 Normal 180 Day Track
S004 2005-10-24 Panel Track
S003 2005-04-01 Normal 180 Day Track
S002 2005-01-31 Real-time Process
S001 2004-05-21 Normal 180 Day Track No User Fee

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.